Kalbe Farma Tbk PT banner

Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 750 IDR 3.45% Market Closed
Market Cap: Rp35.1T

Wall St Price Targets

KLBF Price Forecast
Based on 14 analysts

+50% Upside
from Rp750 today

Kalbe Farma Tbk PT (KLBF)’s 12-month stock price forecast through October 2027 has a consensus target of Rp1 122, implying 50% upside. The forecast is based on price targets from 14 Wall Street analysts.

KLBF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for KLBF yet.

Kalbe Farma Tbk PT Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is KLBF's stock price target?
Price Target
1 122 IDR

According to Wall Street analysts, the average 1-year price target for KLBF is 1 122 IDR with a low forecast of 828.2 IDR and a high forecast of 1 785 IDR.

What is the Revenue forecast for Kalbe Farma Tbk PT?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for Kalbe Farma Tbk PT?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 8%.

What is the Operating Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 7%.

What is the Pre-Tax Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 6%.

What is the Net Income forecast for Kalbe Farma Tbk PT?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 6%.

Back to Top